Navigation Links
Stryker Announces Change in Chairman of the Board of Directors
Date:10/30/2009

KALAMAZOO, Mich., Oct. 30 //PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that after a highly successful and distinguished 32-year career with Stryker Corporation, John W. Brown, has announced his decision to retire as Chairman of the Board and a Director effective December 31, 2009.

Mr. Brown joined the Company as President and Chief Executive Officer in 1977 and served in those positions until 2003. He has been a Director since 1977 and Chairman of the Board since 1981. Under Mr. Brown's leadership, Stryker has become one of the premier medical technology companies in the world.

In announcing his decision, Mr. Brown commented, "This timing is consistent with my original goal of providing a 5-year overlap with Steve MacMillan. The Company has done very well under Steve's leadership as CEO since January 2005, in spite of the challenges in today's economy and the current healthcare environment. We are also extremely fortunate to have a group of strong board members, many of whom have served the Company for a number of years. Additionally, three new members have joined the board during the last few years and are very experienced. This gives me great confidence that the Company is in good hands."

In recognition of Mr. Brown's tremendous contributions to the Company, the Board of Directors has appointed him Chairman Emeritus effective January 1, 2010. While he will no longer play an active role with the Company, Mr. Brown will be available for consultation to the Board.

The Company also announced that Stephen P. MacMillan, Stryker's President and CEO, has been appointed Chairman of the Board, in addition to his current responsibilities, effective January 1, 2010.

In announcing these changes, the Board of Directors commented that they were extremely grateful to Mr. Brow
'/>"/>

SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Strykers Biotech Division Receives FDA Warning Letter
2. Stryker Operating Results for Quarter Ended September 30, 2009
3. Stryker Biotech and its Top Management Indicted for Illegal Promotion of Medical Devices Used in Invasive Surgeries
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... 2 MedAvante, Inc., the leader in centralized evaluation of central nervous ... Service for trials assessing Alzheimer,s Disease. Its CQC Services are already in use ... in the United States , Europe , Asia , ... , , ...
... HARBIN, China , June 2 /PRNewswire-Asia-FirstCall/ ... a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional Chinese ... a conference call at 9:00 a.m. Eastern Time ... for the second quarter of its,fiscal year 2010, ended ...
Cached Medicine Technology:MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimer's Disease Trials 2MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimer's Disease Trials 3Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 3
(Date:12/21/2014)... December 21, 2014 Recently, one of ... LunaDress Prom Shop has introduced its new ... Sale, offering big discounts on all its prom dresses ... , LunaDress insists on providing top quality dress products ... it is considered as one of the best prom ...
(Date:12/21/2014)... AZ (PRWEB) December 21, 2014 Parker ... range of heating, cooling, plumbing and other similar home ... in 2014 with regard to its expert contracting services. ... industry leader that has been serving Arizona for well ... in providing the absolute best in quality customer service ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 As ... alleging heart attacks, stroke and blood clots from using ... increase, a new study shows that the male hormone ... cancer. In a study published in the Proceedings of ... James Amos-Landgraf examined a group of male rats with ...
(Date:12/20/2014)... is a professional company offering many kinds of ... its new engineered bamboo flooring collection, and announced a ... BambooIndustry.com’s customers come from many countries in the world: ... CEO of the company, the global bamboo flooring market ... years, and the demand for eco-friendly bamboo flooring products ...
(Date:12/20/2014)... 20, 2014 An improving macroeconomic landscape ... benefited the Massage Services industry over the ... industry products, the anticipated 1.0% annualized increase in per ... consumers with the means to afford additional massages. “While ... massage in a given year has declined from 2009 ...
Breaking Medicine News(10 mins):Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... MONDAY, March 26 (HealthDay News) -- In a small ... secondary tumors in patients with incurable breast cancer. ... treatment for metastatic tumors in individual patients, although the ... therapy provides a minimal rate of cancer recurrence and ...
... Lisa Esposito HealthDay Reporter , MONDAY, March 26 ... Syndrome (SIDS) dropped by more than 50 percent following the ... to sleep on their backs, new research suggests that risk ... have not declined further. Chief among those other risk ...
... A novel oral anti-coagulant outperformed the injected standard ... long-term treatment of pulmonary embolism a blockage ... clot and showed comparable efficacy, according to ... the American College of Cardiology,s 61st Annual Scientific ...
... ) physicians report that managing chest pain patients within an ... and cardiologists is safe and effective and may lower the ... patients were jointly managed and when stress testing was largely ... lower and there was a low rate of 30-day major ...
... new study has found that very few young women with ... therapy. Also, certain groups of young women are more likely ... Cancer , a peer-reviewed journal of the American Cancer Society, ... on fertility preservation in reproductive-aged women diagnosed with cancer. ...
... Austria: Testing a breast cancer tumour for its genomic ... systemic therapy (additional chemotherapy) after surgery, and spare its ... according to the results of a study to be ... today (Thursday). Dr. Sabine Linn, an Associate Professor of ...
Cached Medicine News:Health News:'Freezing' Secondary Breast Cancer Tumors Shows Promise 2Health News:Bed-Sharing, Smoking Play Role in Sudden Infant Death 2Health News:Bed-Sharing, Smoking Play Role in Sudden Infant Death 3Health News:Novel drug in pill form safer than standard approach to treat blocked lung blood vessels 2Health News:Novel drug in pill form safer than standard approach to treat blocked lung blood vessels 3Health News:ED chest pain units and physician discretion may lower stress test use 2Health News:Few young women with cancer take steps to preserve fertility during treatments 2Health News:New genomic test spares patients chemotherapy with no adverse effect on survival 2Health News:New genomic test spares patients chemotherapy with no adverse effect on survival 3
The Oculus easyfield is an exciting new compact perimeter to do automatic static perimetry up to 30 degrees eccentricity. It has been designed for the combined use as a visual field screener and peri...
... accurate detections of any ... as glaucoma in the ... performed. Smooth operation of ... High accuracy of static ...
... breakthrough in visual field testing that's so efficient ... FDT, the first visual field instrument that's simple ... used even in pre-test. Affordably priced FDT has ... to validate performance. The instrument produce screening results ...
... the latest breakthrough in visual field ... Humphrey Matrix will help you conduct ... assess treatment alternatives. Enhanced patient management ... long-term glaucoma care for your patients, ...
Medicine Products: